Entertainer, Not Influencer
Bhuvan Bam is one of India’s most popular content creators on social media. But it’s his ‘regular boy from Delhi’ image that makes audiences and brands swoon over him
Shruti Sonal - October 30, 2021
Sports NFTs — A Brave New World
The term NFT, which was non-existent in Google search until a year ago, is one of the hottest topics today
Hitanshu Gandhi - October 01, 2021
The quiet of East
The Trucking Industry Is Slowing Down On The Howrah-Dhanbad-Bodh Gaya Route And The Drivers Are Hoping For Deliverance, Even Through Divine Intervention
Himanshu Kakkar - May 13, 2020
The bitter truth
In Bottle of Lies: Ranbaxy and The Dark Side of Indian Pharma, author Katherine Eban investigates the fall of Ranbaxy — a doom of its own making
September 27, 2019
The Eclipse of A Star
Investors worry about poor corporate governance practices at Sun Pharma and price erosion in the US generics market
Prathamesh Mulye - March 25, 2019
"No matter how sincere your efforts though, the competition will never let go of things easily"
Secret Diary of Ajay Piramal — Part 2
N Mahalakshmi - May 04, 2018
Homesick
Rising chronic illnesses and increasing health insurance coverage will spur domestic pharma industry growth
January 02, 2018
"The more pain a strategy extracts from you, the less likely you are to stick with it"
Tobias Carlisle reveals his deep value investing magic formula
N Mahalakshmi - August 22, 2017
Debunking The Rational Individual
You're only as smart as your community declare cognitive scientists Steven Sloman and Philip Fernbach in The Knowledge Illusion
August 24, 2017
Early Mover
What makes Intas the most valuable privately-held pharma company in India
Krishna Gopalan - June 09, 2017